Consumer Discretionary • Catalog/Specialty Distribution
$14.37 ▼ -0.20
(-1.37%)
MKT CAP: $25.83B • VOL: 13.53M
52W L $13 52W H $32
CPNG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $34.53B | $30.27B | $24.38B |
| YoY Revenue Growth % | +14.1% | +24.1% | — |
| Gross Profit | $10.14B | $8.83B | — |
| Gross Margin % | 29.4% | 29.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $473.0M | $436.0M | $473.0M |
| Operating Margin % | 1.4% | 1.4% | 1.9% |
| Net Income (GAAP) | $208.0M | $154.0M | $1.36B |
| EBITDA (Normalized) | $1.47B | $1.14B | $1.35B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.77B | $1.89B | $2.65B |
| Capital Expenditures (CapEx) | $1.25B | $879.0M | $1.10B |
| Free Cash Flow (FCF) | $522.0M | $1.01B | $1.55B |
| FCF Margin % | 1.5% | 3.3% | 6.4% |
| Return on Invested Capital (ROIC %) | 8.8% | 10.4% | 2.1% |
| Cash & Short-Term Equivalents | $6.32B | $5.88B | — |
| Total Debt (Short + Long Term) | $5.92B | $5.03B | $6.85B |
| Total Stockholders' Equity | $4.62B | $4.18B | $14.04B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CPNG.